
Soleno Therapeutics SLNO
$ 39.63
0.56%
Quarterly report 2025-Q3
added 11-04-2025
Soleno Therapeutics EV - Enterprise Value 2011-2026 | SLNO
Annual EV - Enterprise Value Soleno Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.95 B | 657 M | 18.9 M | -1.66 M | 126 M | 112 M | 25.7 M | 11 M | 12.5 M | 12.1 M | 12.5 M | 38.2 M | 36.7 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.95 B | -1.66 M | 232 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.73 | -1.86 % | $ 61.9 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 29.0 | -3.07 % | $ 316 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 23.87 | -0.13 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.14 | -2.16 % | $ 1.45 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Celcuity
CELC
|
506 M | $ 104.95 | -1.72 % | $ 4.14 B | ||
|
Co-Diagnostics
CODX
|
29.3 M | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 210.56 | -0.33 % | $ 154 B | ||
|
Castle Biosciences
CSTL
|
665 M | $ 29.41 | -6.17 % | $ 817 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 202.21 | -0.11 % | $ 22.4 B | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
28.2 B | $ 73.08 | 1.11 % | $ 28.5 B | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 11.75 | 2.8 % | $ 333 M | ||
|
CareDx, Inc
CDNA
|
644 M | $ 18.83 | -5.23 % | $ 1.01 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Illumina
ILMN
|
15.3 B | $ 117.53 | -2.06 % | $ 18.7 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 23.18 | -0.39 % | $ 701 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | $ 103.45 | 0.15 % | $ 19.5 B | ||
|
Lantheus Holdings
LNTH
|
6.44 B | $ 74.31 | 1.54 % | $ 5.14 B | ||
|
Guardant Health
GH
|
15.2 B | $ 103.36 | -2.84 % | $ 13 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 99.61 | 1.22 % | $ 8.22 B | ||
|
Interpace Biosciences
IDXG
|
19.7 M | $ 1.85 | 2.78 % | $ 8.12 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 169.68 | 3.11 % | $ 8.41 B | ||
|
IDEXX Laboratories
IDXX
|
39.1 B | $ 635.6 | 0.77 % | $ 52.4 B | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 166.19 | -1.87 % | $ 28.6 B | ||
|
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 31.19 | 0.73 % | $ 20 B | ||
|
Biodesix
BDSX
|
142 M | $ 13.26 | 4.0 % | $ 1.72 B | ||
|
Quidel Corporation
QDEL
|
460 M | $ 22.47 | -4.85 % | $ 947 M | ||
|
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 283.38 | 0.32 % | $ 23.8 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.17 | -2.25 % | $ 4.98 M | ||
|
Bioventus
BVS
|
904 M | $ 8.57 | -0.06 % | $ 537 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 452.99 | 1.47 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
National Research Corporation
NRC
|
1.08 B | $ 13.65 | 9.64 % | $ 335 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 378.44 | 0.14 % | $ 28.4 B |